DMD and Duchenne muscular dystrophy: Upon the genome editing in DMD patient-derived myoblasts, dystrophin expression was ameliorated in vitro, and more importantly dystrophin was identified in vivo after transplantation of genetically modified myoblasts into immunodeficient mice (Ousterout et al., 2015).